5 years of historical data (2020–2024) · Healthcare · Medical - Devices
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Anteris Technologies Global Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $237M | $113M | — | — | — | — |
| Enterprise Value | $168M | $44M | — | — | — | — |
| P/E Ratio → | -1.75 | — | — | — | — | — |
| P/S Ratio | 87.79 | 41.81 | — | — | — | — |
| P/B Ratio | 2.13 | 1.80 | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 16.26 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Anteris Technologies Global Corp. earns an operating margin of -2899.4%. Operating margins have compressed from -972.1% to -2899.4% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -187.0% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 46.8% | 46.8% | 32.1% | 9.3% | 32.7% | 61.5% |
| Operating Margin | -2899.4% | -2899.4% | -1760.3% | -972.1% | -289.2% | -243.0% |
| Net Profit Margin | -2822.5% | -2822.5% | -1682.8% | -954.9% | -294.5% | -215.8% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | -187.0% | -187.0% | -329.5% | -312.5% | -277.4% | -634.5% |
| ROA | -137.2% | -137.2% | -197.9% | -163.4% | -110.1% | -120.7% |
| ROIC | — | — | -45271.9% | — | -4070.3% | — |
| ROCE | -183.9% | -183.9% | -310.5% | -293.8% | -225.6% | -357.5% |
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $70M exceeds total debt of $1M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.08 | 0.11 | 0.39 | 1.57 |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | -1.10 | -1.03 | -0.92 | -1.08 | -0.24 |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -955.76 | -955.76 | -717.55 | -47.96 | -16.30 | -44.11 |
Net cash position: cash ($70M) exceeds total debt ($1M)
Short-term solvency ratios and asset-utilisation metrics
Anteris Technologies Global Corp.'s current ratio of 4.51x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.02x to 4.51x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 4.51 | 4.51 | 2.56 | 2.02 | 1.84 | 1.03 |
| Quick Ratio | 4.48 | 4.48 | 2.51 | 1.97 | 1.78 | 0.94 |
| Cash Ratio | 4.25 | 4.25 | 2.22 | 1.54 | 1.52 | 0.56 |
| Asset Turnover | — | 0.03 | 0.09 | 0.20 | 0.27 | 0.56 |
| Inventory Turnover | 2.80 | 2.80 | 4.20 | 8.16 | 7.14 | 3.93 |
| Days Sales Outstanding | — | 51.72 | 246.29 | 172.72 | 115.94 | 43.63 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Anteris Technologies Global Corp. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $20M | $36M | $36M | $36M | $36M |
Compare AVR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $237M | -1.7 | — | — | 46.8% | -2899.4% | -187.0% | — | — | |
| $2B | -14.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — | |
| $130M | -2.2 | — | — | 79.8% | -25.5% | -58.9% | -31.0% | — | |
| $1B | -109.5 | 73.2 | 27.6 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 | |
| $46B | 43.7 | 24.5 | 34.5 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 | |
| $73M | -4.3 | — | — | 58.2% | -10.3% | -34.9% | -12.8% | — | |
| $1B | 121.0 | 29.7 | — | 61.3% | 6.1% | 2.7% | 3.2% | 5.9 | |
| $98B | 21.1 | 14.1 | 18.8 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 | |
| $147B | 11.0 | 15.4 | 23.1 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 | |
| $80B | 27.8 | 24.2 | 21.9 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 | |
| $109B | 34.0 | 19.8 | 25.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 | |
| Healthcare Median | — | 21.9 | 14.2 | 18.5 | 64.3% | -5.0% | -34.0% | -11.0% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 5 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs NovoCure Limited.
Start ComparisonQuick answers to the most common questions about buying AVR stock.
Anteris Technologies Global Corp.'s current P/E ratio is -1.7x. This places it at the 50th percentile of its historical range.
Anteris Technologies Global Corp.'s return on equity (ROE) is -187.0%. The historical average is -276.6%.
Based on historical data, Anteris Technologies Global Corp. is trading at a P/E of -1.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Anteris Technologies Global Corp. has 46.8% gross margin and -2899.4% operating margin.